Company intelligence / Profile preview

Fresh Medical Laboratories

Salt Lake City, Utah, United Statesblueaxis.com ↗

Ownership: Private
Development stage: Other

Overview

Fresh Medical Laboratories developed and commercialized the EPN Scan®, a non-invasive diagnostic device designed to assist in the early detection of lung cancer. The system features an improved graphical user interface and internationalization capabilities for global distribution. The company has focused on enhancing data quality and technician usability, aiming to improve patient experience and reduce resource demands. There are no published clinical trial results or peer-reviewed studies cited in available sources.

Therapeutic areas: Oncology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Blue Axis Technologies assisted with design, architecture, and development enhancements for the EPN Scan® technology

Beyond the preview

Go deeper on Fresh Medical Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fresh Medical Laboratories.

Explore the full profile